Xenetic Biosciences Inc, Baxter deal

The partners amended a 2005 deal under which Xenetic (formerly Lipoxen plc) granted Baxter exclusive rights to Xenetic's polysialic acid (PSA) technology in

Read the full 233 word article

How to gain access

Continue reading with a
two-week free trial.